Loading...
Metformin Hcl. 500mg + Glimpride 2 mg (Bilayered Tablets)
A dual-action oral antidiabetic formulation designed for improved glycemic control in patients with type 2 diabetes mellitus. STELTOG-G2 combines metformin and glimepiride in a bilayered tablet to enhance insulin secretion while reducing hepatic glucose production and insulin resistance.
A dual-action oral antidiabetic formulation designed for improved glycemic control in patients with type 2 diabetes mellitus. STELTOG-G2 combines metformin and glimepiride in a bilayered tablet to enhance insulin secretion while reducing hepatic glucose production and insulin resistance.
Contains Metformin, a biguanide that improves insulin sensitivity and lowers glucose production, and Glimepiride, a sulfonylurea that stimulates insulin release from pancreatic beta cells for effective blood sugar control.
Glimepiride stimulates the pancreas to release insulin by acting on pancreatic β-cells, helping lower elevated blood glucose levels, particularly after meals.
Metformin decreases glucose production in the liver and improves peripheral glucose uptake, resulting in better insulin sensitivity and reduced insulin resistance.
Bilayered Tab...
Product descriptions, dosage forms, and compositions listed on the website are for reference by licensed practitioners and distributors only.
